null result

  1. SNT Gatchaman

    Paxlovid shows organ-specific and age-specific impacts on risk of developing post-acute sequelae of COVID-19, 2026, Azhir et al.

    Paxlovid shows organ-specific and age-specific impacts on risk of developing post-acute sequelae of COVID-19 BACKGROUND The impact of antiviral therapies, including Paxlovid, on post-acute sequelae of COVID-19 (PASC) remains inconclusive. METHODS We analyzed data from 19,413 patients (age >...
  2. J

    Preprint Autoantibody landscapes in neurological Long COVID and post-COVID cognitive impairment show heterogeneity without a shared disease signature Chakravar

    Abstract Background: Neurological Long COVID (n-LC) includes persistent cognitive and autonomic symptoms after SARS-CoV-2 infection. Prior studies of post-COVID conditions have described diverse humoral autoreactivity, but findings are heterogeneous, and it remains unclear whether n-LC is...
  3. SNT Gatchaman

    Preprint A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002…, 2026, Peluso+

    A phase 2a double-blind, placebo-controlled randomized trial of the SARS-CoV-2-specific monoclonal antibody AER002 in people with Long COVID Long COVID is a disabling chronic illness with no proven treatments. Persistence of SARS-CoV-2 has been proposed as a biological driver of the disease...
  4. Dolphin

    Stretching exercises or walking did not produce clinically meaningful improvements in quality of life of patients with fibromyalgia,2026, Pontes-Silva

    https://www.sciencedirect.com/science/article/abs/pii/S0211563826000015 Fisioterapia Available online 2 March 2026 In Press, Corrected ProofWhat’s this? Original A. Pontes-Silva, M.A. Avila https://doi.org/10.1016/j.ft.2026.01.001Get rights and content Abstract Overview Considering that...
  5. SNT Gatchaman

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study, 2026, Koller+

    Treatment effects of multimodal inpatient psychotherapy for post-COVID patients: First results from a non-randomized, controlled study BACKGROUND Evidence-based treatment options for post-COVID syndrome remain limited. This study evaluated the effectiveness of a five-week inpatient...
  6. SNT Gatchaman

    Trial Report Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19, 2026, Lim et al.

    Neither Metformin nor Ursodeoxycholic Acid Effectively Treats Postacute Sequelae of COVID-19 BACKGROUND There is no proven treatment to alleviate symptoms of postacute sequelae of SARS-CoV-2 infection (PASC), despite its substantial public health burden. OBJECTIVE To evaluate the efficacy of...
  7. SNT Gatchaman

    Preprint Exploratory analyses of Immunologic Features in a Randomized, Placebo-Controlled Trial of Nirmatrelvir/Ritonavir for [LC], 2026,Bhattacharjee,Iwasaki+

    Exploratory analyses of Immunologic Features in a Randomized, Placebo-Controlled Trial of Nirmatrelvir/Ritonavir for Long COVID This exploratory analysis of PAX LC, a Phase 2, 1:1 randomized, double-blind, superiority, placebo-controlled trial examined whether treatment with...
  8. Utsikt

    The causal status of pain catastrophizing: an experimental test with healthy participants, 2005, Severeijns et al

    The causal status of pain catastrophizing: an experimental test with healthy participants Severeijns, Rudy; van den Hout, Marcel A.; Vlaeyen, Johan W.S. Abstract In the current study we report findings on the effects of experimentally induced catastrophizing about pain on expected pain...
  9. Chandelier

    Is long-term disruption of the renin-angiotensin-aldosterone system associated with LC?A retrospective cohort study healthcare workers,2026,Lange-Tal

    Full title: Is long-term disruption of the renin-angiotensin-aldosterone system associated with long COVID? A retrospective cohort study among healthcare workers https://link.springer.com/article/10.1186/s12879-026-12527-z Previous link that required a login...
  10. Andy

    Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies... 2025 Ariza et al

    Full title: Chronic Reactivation of Persistent Human Herpesviruses EBV, HHV-6 and VZV and Heightened Anti-dUTPase IgG Antibodies Are a Recurrent Hallmark in Post-Infectious ME/CFS and is Associated With Fatigue ABSTRACT Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a...
  11. Utsikt

    Trial Report Effectiveness of a group-based self-management program for people with chronic fatigue syndrome: a randomized controlled trial, 2016, Pinxsterhuis et

    Effectiveness of a group-based self-management program for people with chronic fatigue syndrome: a randomized controlled trial Abstract Objective: To evaluate the effectiveness of a group-based self-management program for people with chronic fatigue syndrome. Design: A randomized controlled...
  12. J

    Evaluation of Interventions for Cognitive Symptoms in Long COVID, 2025, Knopman et al

    https://recovercovid.org/news/recover-neuro-clinical-trial-shares-results-three-non-drug-treatments-cognitive-symptoms-long In other words, didn’t work.
  13. SNT Gatchaman

    Trial Report Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial, 2025, Bassi et al.

    Effectiveness of Colchicine for the Treatment of Long COVID: A Randomized Clinical Trial IMPORTANCE Long COVID is characterized by persistent symptoms after SARS-CoV-2 infection, with inflammation playing a key role in pathogenesis. Colchicine, an established anti-inflammatory agent, may...
  14. forestglip

    Trial Report Preliminary evaluation of a cognitive rehabilitation intervention for post-COVID-19 cognitive impairment: A pilot [RCT], 2025, Becker et al

    Preliminary evaluation of a cognitive rehabilitation intervention for post-COVID-19 cognitive impairment: A pilot randomized controlled trial Jacqueline H. Becker, Eric Watson, Nadia Zubair, Fernando Carnavali, Emilia Bagiella, David Reich, Juan P. Wisnivesky Background: Despite the profound...
  15. Dolphin

    Trial Report Pacing, conventional physical activity and active video gaming to increase physical activity levels for ME/CFS: pilot feasibility study, 2025, Tarca +

    https://www.degruyterbrill.com/document/doi/10.1515/teb-2025-0017/html Pacing, conventional physical activity and active video gaming to increase physical activity levels for adults with myalgic encephalomyelitis/chronic fatigue syndrome: a pilot feasibility study Brett Tarca , Kade Davison ...
  16. SNT Gatchaman

    The Effects of a Mindfulness-Based Intervention on Depression and Anxiety in the Long-COVID Population, 2025 , Welbel et al.

    The Effects of a Mindfulness-Based Intervention on Depression and Anxiety in the Long-COVID Population Long-COVID is a complicated, post-viral syndrome involving multiple body systems and can present with neuropsychiatric symptoms. Little has been reported about the neuropsychiatric symptoms...
  17. Andy

    PBC-HOPE: A randomized controlled trial of hypnosis and psychoeducation in women with primary biliary cholangitis and fatigue 2025 Untas et al

    Abstract Objectives: Fatigue is the main symptom of primary biliary cholangitis (PBC), but has not yet been improved by any therapeutic intervention. This study evaluated the efficacy and safety of hypnosis and psychoeducation in improving fatigue associated with PBC (PBC-HOPE ClinicalTrial.gov...
  18. forestglip

    Trial Report Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: [placebo RCT], 2025, D’hoore+

    Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial Leen D’hoore, Peter Germonpré, Bert Rinia, Leonard Caeyers, Nancy Stevens, Costantino Balestra [Line breaks...
  19. Dolphin

    Health outcomes of patients in the Complex Chronic Diseases Program, 2025, Meagher, Nacul, et al.

    Now published, see post #4 ------------------------------------ Free: https://www.medrxiv.org/content/10.1101/2024.05.25.24307912v1 Complex Chronic Diseases Program: Program Description & Health Outcomes Assessment from a Clinical Data Registry Emily Meagher, Tianna Magel, Travis Boulter...
  20. Andy

    Review Efficacy of Low-Dose Naltrexone in Treating Patients with Fibromyalgia: systematic Review and Meta-Analysis 2025 Ologunowa et al

    Abstract Low-dose naltrexone (LDN) has demonstrated mixed efficacy in treating fibromyalgia. This systematic review and meta-analysis aimed to evaluate the efficacy of LDN for fibromyalgia. We systematically searched electronic databases and gray literature from inception to May 2024. Included...
Back
Top Bottom